Eric Dobmeier Janux Therapeutics, Inc. (JANX) insider trading activity

JANX Quotes by TradingView

Eric Dobmeier is of Janux Therapeutics, Inc.. Currently has a direct ownership of 9,981 shares of JANX, which is worth approximately $230,860. The most recent transaction as insider was on Jun 11, 2025, when has been sold 3,750 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.98K
33.08% 3M change
n/a 12M change
Total Value Held $230,860

ERIC DOBMEIER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 11 2025
BUY
Grant, award, or other acquisition
-
3,750 Added 27.31%
9,981 Common Stock
Jul 19 2024
BUY
Grant, award, or other acquisition
-
7,500 Added 50.0%
7,500 Common Stock

Also insider at

ADPT
Adaptive Biotechnologies Corp Healthcare
Director
KDNY
CHINOOK THERAPEUTICS, INC. Healthcare
President, CEO
ATRA
Atara Biotherapeutics, Inc. Healthcare
AVTE
Aerovate Therapeutics, Inc. Healthcare
GPCR
Structure Therapeutics Inc.
ED

Eric Dobmeier

Seattle, WA

Track Institutional and Insider Activities on JANX

Follow Janux Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JANX shares.

Notify only if

Insider Trading

Get notified when an Janux Therapeutics, Inc. insider buys or sells JANX shares.

Notify only if

News

Receive news related to Janux Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on JANX